Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of NCGC00024596-06 on PharmaCompass.com

    Client Email Product

    NCGC00024596-06

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    38
    US DMFs Filed

    US DMFs Filed

    20
    CEP/COS Certifications

    CEP/COS Certifications

    15
    JDMFs Filed

    JDMFs Filed

    8
    Other Certificates

    Other Certificates

    1
    Other Suppliers

    Other Suppliers

    18
    API REF. PRICE (USD / KG)
    361

    API Market Place

    10
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    112
    Europe

    Europe

    137
    Canada

    Canada

    18
    Australia

    Australia

    5
    South Africa

    South Africa

    12
    Uploaded Dossiers

    Uploaded Dossiers

    29
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    512.00

    Annual Reports

    430.00

    FDF Market Place

    9
    EXCIPIENTS
    317
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    65

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    4

    News

    64
    REF STANDARD

    EDQM

    3

    USP

    2

    JP

    1

    Other Listed Suppliers

    7
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 10MG;100MG
    • TABLET;ORAL - 25MG;100MG
    • TABLET;ORAL - 25MG;250MG
    • TABLET;ORAL - 25MG
    • TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 12.5MG;200MG;50MG
    • TABLET;ORAL - 18.75MG;200MG;75MG
    • TABLET;ORAL - 25MG;200MG;100MG
    • TABLET;ORAL - 31.25MG;200MG;125MG
    • TABLET;ORAL - 37.5MG;200MG;150MG
    • TABLET;ORAL - 50MG;200MG;200MG
    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    AVION PHARMS

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      CARBIDOPA; LEVODOPA

      PDF Supplier PDF
      URL Supplier Web Content
      11033521
      Y
      2039-03-28
      U-3305
      214869
      1
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      AVION PHARMS

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        CARBIDOPA; LEVODOPA

        PDF Supplier PDF
        URL Supplier Web Content
        11033521
        Y
        2039-03-28
        U-3304
        214869
        1
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        AVION PHARMS

        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          CARBIDOPA; LEVODOPA

          PDF Supplier PDF
          URL Supplier Web Content
          11033521
          Y
          2039-03-28
          U-219
          214869
          TREATMENT OF PARKINSON'S DISEASE
          1
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          AVION PHARMS

          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            11439613
            2039-03-28
            U-3557
            214869
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9533046
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1720
            203312
            METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1720
            203312
            METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1647
            203312
            TREATMENT OF PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1646
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8377474
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1649
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8557283
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1646
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1649
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8557283
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1646
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1720
            203312
            METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089608
            Y
            2028-12-26
            203312
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9901640
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1646
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8377474
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1649
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9901640
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9533046
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1649
            203312
            TREATMENT OF POST-ENCEPHALITIC PARKINSONISM
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9533046
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089607
            Y
            2028-12-26
            U-1720
            203312
            METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089608
            Y
            2028-12-26
            203312
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8557283
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8557283
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8557283
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8377474
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8377474
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8377474
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9901640
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1647
            203312
            TREATMENT OF PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8454998
            Y
            2028-12-26
            U-1647
            203312
            TREATMENT OF PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION
            4
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9533046
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            1
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            8557283
            Y
            2028-12-26
            U-1645
            203312
            TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9901640
            Y
            2028-12-26
            U-219
            203312
            TREATMENT OF PARKINSON'S DISEASE
            2
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            IMPAX LABS INC

            Contact Supplier
            • FDA
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARBIDOPA; LEVODOPA

            PDF Supplier PDF
            URL Supplier Web Content
            9089608
            Y
            2028-12-26
            203312
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content
            Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
            Ask Us for Pharmaceutical Supplier and Partner
            Ask Us, Find A Supplier / Partner
            No Commissions, No Strings Attached, Get Connected for FREE

            What are you looking for?

            How can we help you?

            The request can't be empty

            Please read our Privacy Policy carefully

            You must agree to the privacy policy

            The name can't be empty
            The company can't be empty.
            The email can't be empty Please enter a valid email.
            The mobile can't be empty
            polpharma-m-2024-04-15

            Access Virtual Booth

            Contact Supplier

            View Presentation

            LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

            Access Virtual Booth

            Contact Supplier

            View Presentation

            Post Enquiry
            POST ENQUIRY

            Market Place

            Market Place

            PharmaCompass

            Home

            Market Place

            Menu

            Post Enquiry

            Post Enquiry

            Market Place

            Market Place

            Search